Free Trial

Novozymes A/S (OTCMKTS:NVZMY) Short Interest Down 86.1% in July

Novozymes A/S logo with Basic Materials background

Key Points

  • Novozymes A/S experienced a significant decrease in short interest, dropping by 86.1% to 7,600 shares as of July 31st.
  • The company's current stock price is $65.53, with a market capitalization of $30.69 billion and a price-to-earnings ratio of 41.48.
  • Novozymes A/S provides a range of products including industrial enzymes and probiotics for various sectors globally.
  • Need better tools to track Novozymes A/S? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report) saw a large drop in short interest during the month of July. As of July 31st, there was short interest totaling 7,600 shares, adropof86.1% from the July 15th total of 54,500 shares. Based on an average daily volume of 99,800 shares, the short-interest ratio is presently 0.1 days. Approximately0.0% of the shares of the stock are sold short. Approximately0.0% of the shares of the stock are sold short. Based on an average daily volume of 99,800 shares, the short-interest ratio is presently 0.1 days.

Novozymes A/S Price Performance

Shares of NVZMY traded down $0.24 during midday trading on Monday, hitting $64.75. The company's stock had a trading volume of 434 shares, compared to its average volume of 36,852. The company's fifty day simple moving average is $70.13 and its two-hundred day simple moving average is $64.78. The stock has a market capitalization of $30.32 billion, a price-to-earnings ratio of 40.98, a price-to-earnings-growth ratio of 1.23 and a beta of 0.90. Novozymes A/S has a one year low of $53.95 and a one year high of $75.99. The company has a quick ratio of 1.04, a current ratio of 1.66 and a debt-to-equity ratio of 0.11.

Novozymes A/S Company Profile

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

Recommended Stories

Should You Invest $1,000 in Novozymes A/S Right Now?

Before you consider Novozymes A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novozymes A/S wasn't on the list.

While Novozymes A/S currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines